Literature DB >> 5264439

Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission.

A H Ragab, R S Frech, T J Vietti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5264439     DOI： 10.1002/1097-0142(197003)25:3<580::aid-cncr2820250313>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  27 in total

1.  Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

2.  Medial tibial stress syndrome due to methotrexate osteopathy.

Authors:  P Alonso-Bartolome; V M Martinez-Taboada; A Canga; R Blanco
Journal:  Ann Rheum Dis       Date:  2006-06       Impact factor: 19.103

Review 3.  Cancer therapies and bone health.

Authors:  Mimi I Hu; Huifang Lu; Robert F Gagel
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

4.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

5.  Anticonvulsant drugs, folate deficiency, and metabolic bone disease.

Authors:  E H Reynolds
Journal:  Br Med J       Date:  1972-06-10

Review 6.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

Review 7.  Methotrexate osteopathy: five cases and systematic literature review.

Authors:  F Robin; S Cadiou; J-D Albert; G Bart; G Coiffier; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2020-10-30       Impact factor: 4.507

8.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Authors:  Mariël L te Winkel; Robert D van Beek; Sabine M P F de Muinck Keizer-Schrama; André G Uitterlinden; Wim C J Hop; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

9.  Effect of chemotherapy on segmental bone healing enhanced by rhBMP-2.

Authors:  Jose A Morcuende; Pablo Gomez; Jeffrey Stack; George Oji; James Martin; Douglas C Fredericks; Joseph A Buckwalter
Journal:  Iowa Orthop J       Date:  2004

10.  Methotrexate osteopathy in rheumatic disease.

Authors:  S J Preston; T Diamond; A Scott; M R Laurent
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.